Analytical & Bioanalytical Method Validation

Change Control Strategies When Modifying Validated Methods During Transfer

Change Control Strategies When Modifying Validated Methods During Transfer Change Control Strategies When Modifying Validated Methods During Transfer Introduction to Change Control and Its Regulatory Framework Change control is a critical component of the quality management system (QMS) in pharmaceutical development and manufacturing. For regulatory authorities such as the US FDA, the European Medicines Agency (EMA), and the Medicines and…

Continue Reading Change Control Strategies When Modifying Validated Methods During Transfer

Inspection Case Studies Focused on Weak Method Transfer Documentation

Inspection Case Studies Focused on Weak Method Transfer Documentation Inspection Case Studies Focused on Weak Method Transfer Documentation In the highly regulated field of pharmaceutical development and manufacturing, the robustness of analytical methods is critical to ensuring product quality and safety. Method transfer, which involves transferring methods between laboratories or sites, is a common practice that can pose significant challenges….

Continue Reading Inspection Case Studies Focused on Weak Method Transfer Documentation

Analytical Method Lifecycle Management – Transfer, Verification and Retirement

Analytical Method Lifecycle Management – Transfer, Verification and Retirement Understanding the Analytical Method Lifecycle The analytical method lifecycle entails an organized approach to the validation and support of analytical methods that are essential for drug development and quality control in the pharmaceutical industry. This lifecycle comprises several key stages: method development, transfer, verification, periodic review, and retirement. Each phase is…

Continue Reading Analytical Method Lifecycle Management – Transfer, Verification and Retirement

Establishing Specificity and Selectivity in Protein-Based Assay Validation

Establishing Specificity and Selectivity in Protein-Based Assay Validation In the realm of pharmaceutical validation, ensuring the accuracy and reliability of protein-based assays is paramount. This article delves into the regulatory expectations surrounding specificity in protein assays, focusing on the concepts of selectivity, cross-reactivity, and interference, and their implications for assay validation. We will explore guidelines set forth by major regulatory…

Continue Reading Establishing Specificity and Selectivity in Protein-Based Assay Validation

Protein Assay Linearity, Accuracy and Precision – Study Design and Analysis

Protein Assay Linearity, Accuracy and Precision – Study Design and Analysis Protein Assay Linearity, Accuracy and Precision – Study Design and Analysis Validation of analytical methods, particularly in the context of protein assay techniques, is pivotal for ensuring compliance with regulatory frameworks such as those set forth by the US FDA, EMA, and PIC/S standards. This comprehensive guide will examine…

Continue Reading Protein Assay Linearity, Accuracy and Precision – Study Design and Analysis

Validation of ELISA and Ligand Binding Assays for Biologic Drug Products

Validation of ELISA and Ligand Binding Assays for Biologic Drug Products Validation of ELISA and Ligand Binding Assays for Biologic Drug Products Introduction to Validation: Regulatory Scope and Importance Validation is a critical component in the pharmaceutical manufacturing process, especially concerning the accuracy and reliability of analytical methods such as Enzyme-Linked Immunosorbent Assays (ELISA) and ligand binding assays for biologic…

Continue Reading Validation of ELISA and Ligand Binding Assays for Biologic Drug Products

Western Blot Assay Validation for Biologics Identity and Potency Testing

Western Blot Assay Validation for Biologics Identity and Potency Testing Western Blot Assay Validation for Biologics Identity and Potency Testing The validation of Western blot assays is a critical aspect of quality control in biologics, particularly concerning identity and potency testing. This comprehensive regulatory explainer manual discusses the fundamentals of Western blot assay validation, emphasizing key guidelines from the US…

Continue Reading Western Blot Assay Validation for Biologics Identity and Potency Testing

Quantitative Western Blot Assays – Validation Strategies and Pitfalls

Quantitative Western Blot Assays – Validation Strategies and Pitfalls Quantitative Western Blot Assays – Validation Strategies and Pitfalls Validation is a critical step in the development of quantitative Western blot assays, particularly in the pharmaceutical industry where regulatory compliance is paramount. This article provides a step-by-step guide to understanding the validation strategies and pitfalls associated with these assays. We will…

Continue Reading Quantitative Western Blot Assays – Validation Strategies and Pitfalls

Validation of Host Cell Protein and Impurity Protein Assays for Biologics

Validation of Host Cell Protein and Impurity Protein Assays for Biologics Introduction to HCP and Impurity Assay Validation The validation of host cell protein (HCP) and impurity assays is critical in the development and regulatory approval of biologics. These assays must ensure that product safety and efficacy standards are met, a requirement outlined by key regulatory bodies including the US…

Continue Reading Validation of Host Cell Protein and Impurity Protein Assays for Biologics

Robustness Testing for Western Blot and ELISA Methods Under GMP

Robustness Testing for Western Blot and ELISA Methods Under GMP In the context of analytical method validation, especially for Western blot and ELISA (Enzyme-Linked Immunosorbent Assay) techniques used in good manufacturing practice (GMP) settings, the concept of robustness is crucial. This article aims to serve as a comprehensive regulatory explainer manual, guiding professionals on robustness testing strategies adhering to regulatory…

Continue Reading Robustness Testing for Western Blot and ELISA Methods Under GMP